Biomed-Lublin to acquire investor

Medical preparations and pharmaceuticals producer Biomed-Lublin has signed an agreement with a financial investor regarding preliminary and non-binding conditions of potential capital transaction valued at PLN 200 million. Conducting due diligence and getting approvals from financial committees of the investor are the conditions that Biomed has to meet in order to receive financing. Biomed is planning to fund a plasma fraction plant in Mielec which will be worth up to PLN 200 million.